Ειδήσεις: VERTEX PHARMACEUTICALS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 19:13 defenseworld.net

Assenagon Asset Management S.A. Has $377.58 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX

Vertex Pharmaceuticals Assenagon Asset Management Q4 holdings institutional investor pharmaceutical stocks SEC filing

24/03 13:27 yahoo.com

Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results

Vertex Pharmaceuticals Truist Securities price target Phase 3 trial biotech drug approval

23/03 11:49 defenseworld.net

Nordea Investment Management AB Has $202.61 Million Position in Vertex Pharmaceuticals Incorporated $VRTX

Nordea Investment Management Vertex Pharmaceuticals hedge fund shareholding institutional investor pharmaceutical

19/03 11:22 defenseworld.net

Danske Bank A S Makes New $64.42 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX

Danske Bank Vertex Pharmaceuticals investment hedge fund 13F filing

19/03 09:54 defenseworld.net

Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to “Buy” at Maxim Group

Vertex Pharmaceuticals buy rating Maxim Group Weiss Ratings HC Wainwright UBS Group

17/03 10:08 defenseworld.net

Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Bamco Inc. NY

Vertex Pharmaceuticals Bamco Inc.share sale institutional investors Nasdaq pharma

16/03 09:29 defenseworld.net

Aquatic Capital Management LLC Acquires Shares of 29,596 Vertex Pharmaceuticals Incorporated $VRTX

Vertex Pharmaceuticals Aquatic Capital Management institutional investors Q3 holdings hedge funds stock acquisition

15/03 09:45 defenseworld.net

Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Ameriprise Financial Inc.

Vertex Pharmaceuticals Ameriprise Financial Q3 holdings institutional investment 13F filing share acquisition

15/03 09:45 defenseworld.net

Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Ameriprise Financial Inc.

Vertex Pharmaceuticals Ameriprise Financial Q3 holdings institutional investment 13F filing share acquisition

Loading...